Bassel Fouad El-Rayes MD

PubMed

• 1 citations
  "Horses out of the barn": pancreatic ductal adenocarcinoma frequently extends beyond the grossly visible tumour, requiring microscopic rectification for accurate T-sta...
  Burcu Saka, Bahar Memis, Serdar Balci, Ipek Erbarut Seven, Burcin Pehlivanoglu
  Histopathology. 2026-06-01
• Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions.
  Ganji Purnachandra Nagaraju, Haasita Nellipudi, Chaithanya Ganji, Vaishnavi Kuppala, Swapna Priya Ganji
  Signal Transduction and Targeted Therapy. 2026-05-05
• High-Dimensional Protein Analysis Uncovers Distinct Immunologic and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma.
  Emily Greene, Natalie K Horvat, Deon Bryant Doxie, Vaunita Cohen Parihar, Jayden Kim
  Cancer Research. 2026-04-02

Journal Articles

• "Heat Shock Protein 90 (HSP90) Promotes Epithelial to Mesenchymal Transition, Invasion, and Migration in Colorectal Cancer"  
  Nagaraju GP, Long TE, Park W, Landry JC,Taliaferro-Smith L, Farris AB, Diaz R, El-Rayes BF, Mol Carcinog, 1/27/2014
• "Cost Effectiveness Analysis of Pharmacokinetically-Guided 5-Fluorouracil in FOLFOX Chemotherapy for Metastatic Colorectal Cancer"  
  Goldstein DA, Chen Q, Ayer T, Howard DH, Lipscomb J, Harvey RD, El-Rayes BF, Flowers CR, Clin Colorectal Cancer, 1/21/2014
• "HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FU-based chemotherapy"  
  Nagaraju GP, Alese OB, Landry J, Diaz R, El-Rayes BF, Oncotarget, 1/16/2014

Books/Book Chapters

• Gastrointestinal Malignancies: New Innovative Diagnostics and Treatment 
  Cai Q, Xu H, El-Rayes B, Staley CAWorld Science Publishing Co. Pte. Ltd., Singapore2013
• Pancreatic Cancer-Clinical Management 
  Chapter: "Pancreatic Neuroendocrine Tumours: Emerging Management Paradigm" 
  Zafar SF, El-Rayes BEditors: S. Srivastava.2012
• Biliary Tract & Gallbladder Cancer: A Multidisciplinary Approach 
  Chapter: Systemic Therapy for Biliary Cancer. 
  El-Rayes B, Philip PEditors: C.R. Thomas & C. D. Fuller.New York, NY2009

Abstracts/Posters

• "Antiangiogenic activity of the HSP90 inhibitor ganetespib in pancreatic cancer models."
  P. N. Ganji, R. Diaz, B. F. El-Rayes, The Federation of American Society for Experimental Biology, 1/1/2013
• "Anti-angiogenic effects of curcumin and its novel analogs EF-31 and UBS-109 in colorectal cancer."
  P. N. Ganji, S. Zhu, J. E. Ko, M. Shoji, B. F. El-Rayes, The Federation of American Society for Experimental Biology, 1/1/2013
• "A comparison of advanced pancreatic cancer patients treated on clinical trials with those from a SEER registry over an 18 year period."
  B.F. El-Rayes, Gastrointestinal Cancers Symposium, 1/1/2008

Lectures

• Hematology/Oncology Grand Rounds, "Pancreatic Cancer: Current Status and Future Directions" 
  University of Cincinnati, Cincinnati, OH - 1/1/2014
• "Optimizing sequencing for colorectal cancer-What is best when?" 
  Sea Island, GA - 1/1/2014
• "A Closer Look at Targeted Therapies in Metastatic Colorectal Cancer" 
  Gaylord Palms Resort, Orlando, FL - 1/1/2013

Other

• "Gastrointestinal Malignancies: New Innovative Diagnostics and Treatment, World Science Publishing Co. Pte. Ltd., Singapore" 
  Cai Q, Xu H, El-Rayes B, Kooby D (editors)
  1/1/2013
• Interview: "Breast Cancer in patients with HIV" 
  Bassel F. El-Rayes, MD, HIV Plus
  1/1/2003